Luxuriate Pharmaceuticals Private Limited
About Luxuriate Pharmaceuticals Private Limited
Data last updated:
Luxuriate Pharmaceuticals Private Limited is a private limited company based in Asansol, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 July 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24100WB2013PTC195191.
The company has an authorised share capital of ₹55 Lakh and a paid-up capital of ₹54 Lakh. It is led by directors Tandra Upadhyay and Kuntal Choubey.
Its last annual general meeting (AGM) was held on 30 September 2016, and its latest financial statements are for the year ended 31 March 2016. The registered office is at 368 S. B. Gorai Road P. O. – Asansol, West Bengal, India – 713301.
As per the financials filed for FY 2015, the company reported a revenue of ₹80.95 Lakh. For the same year it recorded a net profit of ₹12,452 (net margin 0.2%) and EBITDA of ₹5.73 Lakh (EBITDA margin 7.1%).
As per MCA filings, the company has open charges of ₹2.89 Cr on record.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Luxuriate Pharmaceuticals Private Limited's registered office is in Asansol, West Bengal. Its e-mail address is in the company report.
- Email
- Registered Address368 S. B. Gorai Road P. O. – Asansol, West Bengal, India – 713301
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Luxuriate Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Luxuriate Pharmaceuticals Private Limited
FY 2016 filings availableLuxuriate Pharmaceuticals Private Limited reported revenue of ₹80.95 Lakh for FY 2015.
Financial Statement Summary
| Metrics | FY 2014-15 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | ₹80.95 Lakh |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | ₹5.73 Lakh |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | ₹12,452 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2014-15 |
|---|---|
| Profitability | |
| EBITDA Margin | 7.1% |
| Net Profit Margin | 0.2% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Luxuriate Pharmaceuticals Private Limited, buy the company report.
Board of directors of Luxuriate Pharmaceuticals Private Limited
Luxuriate Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tandra Upadhyay | Director | 01 Jul 2013 | 13 Years 4 Months | Current |
| Kuntal Choubey | Director | 03 Jul 2013 | 13 Years 4 Months | Current |
Peer comparison
Luxuriate Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medzone Pharmaceuticals Private Limited | ₹81.23 Lakh (FY 2024) | -24.0% | Puducherry, India | |||
| Rausd Pharma Private Limited | ₹81.2 Lakh (FY 2025) | 9.0% | Darbhanga, Bihar, India | |||
| Sanjivani Therapeutics Private Limited | ₹81.16 Lakh (FY 2024) | 1.0% | Kolkata, West Bengal, India | |||
| Tungabhadra Pharmaceuticals Private Limited | ₹81.13 Lakh (FY 2016) | 0.0% | Mumbai, Maharashtra, India | |||
| Himalaya Pharmaceuticals Limited | ₹81.04 Lakh (FY 2025) | Mansa, Punjab, India | ||||
| Luxuriate Pharmaceuticals Private Limitedthis company | ₹80.95 Lakh (FY 2015) | ₹12,452 | 0.2% | Asansol, West Bengal, India | ||
| Aileron Pharmaceuticals Private Limited | ₹80.87 Lakh (FY 2025) | 15.0% | Jaipur, Rajasthan, India | |||
| Rennova Pharmaceuticals Private Limited | ₹80.86 Lakh (FY 2025) | -40.0% | Kolhapur, Maharashtra, India | |||
| SV Well and Care Pharmaceuticals Private Limited | ₹80.76 Lakh (FY 2025) | -18.0% | Dehradun, Uttarakhand, India | |||
| Abha Biotechnology Private Limited | ₹80.73 Lakh (FY 2024) | 970.0% | Noida, Uttar Pradesh, India | |||
| Belgrand Pharmaceuticals Private Limited | ₹80.59 Lakh (FY 2024) | 21.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Luxuriate Pharmaceuticals Private Limited, buy the company report.
Auditor
Luxuriate Pharmaceuticals Private Limited is audited by S D AND ASSOCIATES for the financial year 2015.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S D AND ASSOCIATES | FY 2015 | 016223C |
Shareholding
The shareholding of Luxuriate Pharmaceuticals Private Limited is on record for FY 2016, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2016 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Luxuriate Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 May 2015 | 10571162 | Uco Bank | ₹2.89 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Luxuriate Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Luxuriate Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Luxuriate Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Luxuriate Pharmaceuticals Private Limited has 3 board changes on record since 2013: 2 appointments and 1 cessation. The latest: Chandan Upadhyay ceased to be Additional Director on 19 Aug 2016.
Frequently asked questions
Luxuriate Pharmaceuticals is an active private limited company based in Asansol, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 July 2013 (13+ years old) and is registered under CIN U24100WB2013PTC195191.
Luxuriate Pharmaceuticals has 2 current directors:
- Tandra Upadhyay - Director
- Kuntal Choubey - Director
The latest financial statements of Luxuriate Pharmaceuticals on record with the MCA are for the year ended 31 March 2016. Its last annual general meeting was held on 30 September 2016. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Luxuriate Pharmaceuticals is U24100WB2013PTC195191. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Luxuriate Pharmaceuticals was incorporated on 01 July 2013, making it 13+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Luxuriate Pharmaceuticals by revenue are Medzone Pharmaceuticals Private Limited, Rausd Pharma Private Limited, Sanjivani Therapeutics Private Limited, Tungabhadra Pharmaceuticals Private Limited, Himalaya Pharmaceuticals Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Chandan Upadhyay ceased to be Additional Director on 19 Aug 2016. Kuntal Choubey was appointed as Director on 03 Jul 2013. Tandra Upadhyay was appointed as Director on 01 Jul 2013.
The registered office of Luxuriate Pharmaceuticals is at 368 S. B. Gorai Road P. O. – Asansol, West Bengal, India – 713301.
Luxuriate Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Luxuriate Pharmaceuticals has open charges of ₹2.89 Cr and no satisfied charges on record as per latest MCA filings.
The compliance status of Luxuriate Pharmaceuticals is active non-compliant as of 02 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
